Upload Avatar (500 x 500)
Jun Qin
qinjun@sibs.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Life Sciences
  • 2000-09--2005-06 PhD: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
  • 1996-09--2000-06 Bachelor's: Sichuan University
  • 2014-02~Present - Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine - Researcher
  • 2012-07~2014-01 - Department of Molecular and Cellular Biology, Baylor College of Medicine - Assistant Professor
  • 2010-06~2016-06 - Department of Molecular and Cellular Biology, Baylor College of Medicine - Lecturer
  • 2005-10~2010-05 - Department of Molecular and Cellular Biology, Baylor College of Medicine - Postdoctoral Fellow
  • 2000-09~2005-06 - Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences - PhD
  • 1996-09~2000-06 - Sichuan University - Bachelor's
  • National Natural Science Foundation of China 'Outstanding Youth Science Fund Continuation Grant' (2024): National Level
  • Shanghai Medical Science Award, First Prize (2023): Provincial Level
  • Ministry of Education Science Research Excellent Achievement Award, First Prize (2023): Ministerial Level
  • Shanghai Science and Technology Award (2023): Provincial Level
  • Chinese Academy of Sciences Leading Goose Award (2022): Institute Level
  • Shanghai Academic Leader Program (2019): Provincial Level
  • National Natural Science Foundation of China 'Outstanding Youth Science Fund' (2018): National Level
  • Central Organization Department 'Youth ****' (2014): Ministerial Level
  • National Natural Science Foundation of China 'Excellent Youth Science Fund' (2014): National Level
Epigenetic Regulation of Tumor Cell Plasticity
  • Targeting JMJD1C to selectively disrupt tumor Treg fitness enhances anti-tumor immunity, Jun Qin, 2024
  • Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer, Jun Qin, 2023
  • ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression, Jun Qin, 2022
  • Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity, Jun Qin, 2022
  • The ZMYND8-regulated Mevalonate Pathway Endows YAP-High Intestinal Cancer with Metabolic Vulnerability, Jun Qin, 2021
  • SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways, Jun Qin, 2020
  • Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer, Jun Qin, 2019
  • Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis, Jun Qin, 2017
  • AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis, Jun Qin, 2017
  • COUP-TFII inhibits TGF-b-induced growth barrier to promote prostate Tumorigenesis, Jun Qin, 2013
Epigenetics Tumor Cell Plasticity Regulation Cancer Gene Expression Histone Modification Dna Methylation Chromatin Oncology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.